Ad therapeutics
12 Questions
3 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the recommended pharmacological approach for people with mild to moderate Alzheimer's disease?

  • Memantine as a first-line treatment
  • No pharmacological treatment is recommended
  • Donepezil, galantamine, or rivastigmine as single agents (correct)
  • Donepezil, galantamine, or rivastigmine in combination with memantine
  • When should memantine be considered for people with Alzheimer's disease?

  • If they have mild disease and are not taking an AChE inhibitor
  • If they have severe disease and are taking an AChE inhibitor
  • If they have moderate disease and are intolerant or have a contraindication to an AChE inhibitor (correct)
  • If they have any severity of disease and are not taking an AChE inhibitor
  • What is the recommended approach for people with dementia with Lewy bodies who are intolerant to AChE inhibitors?

  • Do not consider any pharmacological treatment
  • Consider memantine as a first-line treatment
  • Consider galantamine only if donepezil and rivastigmine are not tolerated (correct)
  • Consider galantamine as a first-line treatment
  • What is the recommended approach for people with vascular dementia?

    <p>Offer AChE inhibitors or memantine only if they have suspected comorbid Alzheimer's disease, Parkinson's disease dementia or dementia with Lewy bodies</p> Signup and view all the answers

    What is the recommended approach for people with Alzheimer's disease who are already taking an AChE inhibitor and have severe disease?

    <p>Consider adding memantine to their treatment</p> Signup and view all the answers

    What is the recommended pharmacological approach for people with mild to moderate dementia with Lewy bodies?

    <p>Offer donepezil or rivastigmine as a first-line treatment</p> Signup and view all the answers

    What is the primary focus of the initial and ongoing management of non-cognitive symptoms in people living with dementia?

    <p>Psychosocial and environmental interventions</p> Signup and view all the answers

    In what circumstances can antipsychotics be offered to people living with dementia?

    <p>When there is a risk of harm to themselves or others, or when experiencing agitation, hallucinations, or delusions causing severe distress</p> Signup and view all the answers

    What should be considered when discussing antipsychotics with the person and their family members or carers?

    <p>Both the benefits and harms of antipsychotics</p> Signup and view all the answers

    What should be avoided in people living with dementia, due to the increased risk of stroke and death?

    <p>Antipsychotics for mild to moderate non-cognitive symptoms</p> Signup and view all the answers

    What should be stopped if no clear ongoing benefit is seen, and after discussion with the person and their family members or carers?

    <p>Antipsychotics</p> Signup and view all the answers

    What is not recommended for managing agitation or aggression in people living with dementia, unless indicated for another condition?

    <p>Valproate</p> Signup and view all the answers

    More Like This

    Alzheimer's Disease and Dementia
    5 questions
    Alzheimer's Disease and Dementia
    10 questions

    Alzheimer's Disease and Dementia

    AccessibleCarnelian3863 avatar
    AccessibleCarnelian3863
    Use Quizgecko on...
    Browser
    Browser